Insmed presents four-study TPIP lung disease trial program at CHEST 2026

October 15, 2026 7:01 AM

Insmed Incorporated (NASDAQ: INSM) presented its PALM Clinical Development Program at the American College of Chest Physicians Annual Meeting 2026 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found